Connection
Jawahar Mehta to Angiotensin Receptor Antagonists
This is a "connection" page, showing publications Jawahar Mehta has written about Angiotensin Receptor Antagonists.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.720 |
|
|
|
-
Barill? F, Bassareo PP, Calcaterra G, Romeo F, Mehta JL. Focus on clinical practice: angiotensin-converting enzyme 2 and corona virus disease 2019: pathophysiology and clinical implications. J Cardiovasc Med (Hagerstown). 2020 09; 21(9):630-633.
Score: 0.734
-
Salah HM, Calcaterra G, Mehta JL. Renin-Angiotensin System Blockade and Mortality in Patients With Hypertension and COVID-19 Infection. J Cardiovasc Pharmacol Ther. 2020 11; 25(6):503-507.
Score: 0.731
-
Chen H, Li D, Mehta JL. Modulation of matrix metalloproteinase-1, its tissue inhibitor, and nuclear factor-kappa B by losartan in hypercholesterolemic rabbits. J Cardiovasc Pharmacol. 2002 Mar; 39(3):332-9.
Score: 0.204
-
Mehta JL, Li DY, Yang H, Raizada MK. Angiotensin II and IV stimulate expression and release of plasminogen activator inhibitor-1 in cultured human coronary artery endothelial cells. J Cardiovasc Pharmacol. 2002 Jun; 39(6):789-94.
Score: 0.052